Z-Arg-Arg-Pro-Phe-His-Sta-Ile-His-Lys(Boc)-Ome is a specific renin inhibitor[1].

Z-Gly-Osu is a Glycine (HY-Y0966) derivative[1].

Z-Gly-Osu is a Glycine (HY-Y0966) derivative[1].

Z-L-2-Nal-OH (Z-2-Nal-OH) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

Z-Val-Val-Arg-AMC is a fluorescent peptide substrate that can be used to test the activity of cathepsins[1].

Z2206320703 is a potential lead candidate compound against IspC[1].

Z32439948 is a butyrylcholinesterase (BChE) inhibitor (IC50: 1.4 μM, hBChE) and is a derivative of m-sulfamoylbenzamide. Z32439948 also exhibited neuroprotective effects against glutamate in SH-SY5Y cells[1].

Z36-MP5 is an Mi-2β-targeted inhibitor, with IC50 of 0.082 μM. Z36-MP5 can reduce Mi-2β ATPase activity and reactivates ISG transcription. Z36-MP5 can stimulate T-cell-mediated cytotoxicity[1].

Z36-MP5 is an Mi-2β-targeted inhibitor, with IC50 of 0.082 μM. Z36-MP5 can reduce Mi-2β ATPase activity and reactivates ISG transcription. Z36-MP5 can stimulate T-cell-mediated cytotoxicity[1].

Z36-MP5 is an Mi-2β-targeted inhibitor, with IC50 of 0.082 μM. Z36-MP5 can reduce Mi-2β ATPase activity and reactivates ISG transcription. Z36-MP5 can stimulate T-cell-mediated cytotoxicity[1].

Z36-MP5 is an Mi-2β-targeted inhibitor, with IC50 of 0.082 μM. Z36-MP5 can reduce Mi-2β ATPase activity and reactivates ISG transcription. Z36-MP5 can stimulate T-cell-mediated cytotoxicity[1].

Z57346765 is a PGK1-specific inhibitor that reduces the activity of metabolic enzymes in PGK1 glycolysis and inhibits PGK1-dependent cell proliferation. Z57346765 exerts inhibitory effects against clear cell renal cell carcinoma (KIRC)[1].

Z57346765 is a PGK1-specific inhibitor that reduces the activity of metabolic enzymes in PGK1 glycolysis and inhibits PGK1-dependent cell proliferation. Z57346765 exerts inhibitory effects against clear cell renal cell carcinoma (KIRC)[1].

Z57346765 is a PGK1-specific inhibitor that reduces the activity of metabolic enzymes in PGK1 glycolysis and inhibits PGK1-dependent cell proliferation. Z57346765 exerts inhibitory effects against clear cell renal cell carcinoma (KIRC)[1].

Z57346765 is a PGK1-specific inhibitor that reduces the activity of metabolic enzymes in PGK1 glycolysis and inhibits PGK1-dependent cell proliferation. Z57346765 exerts inhibitory effects against clear cell renal cell carcinoma (KIRC)[1].

Z57346765 is a PGK1-specific inhibitor that reduces the activity of metabolic enzymes in PGK1 glycolysis and inhibits PGK1-dependent cell proliferation. Z57346765 exerts inhibitory effects against clear cell renal cell carcinoma (KIRC)[1].

Zabicipril is an orally active angiotensin-converting enzyme (ACE) inhibitor. Zabicipril can be used for the study of blood pressure and peripheral arterial insufficiency[1].

ZACN Human Pre-designed siRNA Set A contains three designed siRNAs for ZACN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Zafirlukast-d6 is deuterated labeled Zafirlukast (HY-17492). Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.

ZAN Human Pre-designed siRNA Set A contains three designed siRNAs for ZAN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Zanamivir (Standard) is the analytical standard of Zanamivir. This product is intended for research and analytical applications. Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively.

Zanapezil (TAK-147) is a potent, reversible and selective acetylcholine esterase (AChE) inhibitor. Zanapezil shows a potent and reversible inhibition of AChE activity in homogenates of the rat cerebral cortex (IC50=51.2 nM). Zanapezil shows a moderate inhibition of muscarinic M1 and M2 receptor binding with Ki values of 234 and 340 nM, respectively. Zanapezil can be […]

ZAP70 Human Pre-designed siRNA Set A contains three designed siRNAs for ZAP70 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZAR1 Human Pre-designed siRNA Set A contains three designed siRNAs for ZAR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBBX Human Pre-designed siRNA Set A contains three designed siRNAs for ZBBX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBED1 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBED2 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBED2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBED3 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBED3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBED6 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBED6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB1 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB10 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB11 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB12 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB14 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB16 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB17 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB18 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB2 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB20 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB20 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB24 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB24 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB3 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB32 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB32 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB33 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB33 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB38 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB38 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB4 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB40 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB40 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB43 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB43 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB46 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB46 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ZBTB48 Human Pre-designed siRNA Set A contains three designed siRNAs for ZBTB48 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.